https://de.marketscreener.com/kurs/aktie/ABBISKO-CAYMAN-LIMITED-127830029/news/Abbisko-Therapeutics-hat-die-erste-Patientendosis-in-der-Phase-II-Studie-zum-fortgeschrittenen-Bauch-45450307/?utm_source=telegram&utm_medium=social&utm_campaign=share